SEC 13F Intelligence

Burrage Capital Management LLC / CRNX

Burrage Capital Management LLC’s Crinetics Pharmaceuticals In Position

Does Burrage Capital Management LLC own Crinetics Pharmaceuticals In (CRNX)? Not currently — the last reported position was 294.6K shares worth $6M in Q2 2021; the fund’s latest 13F (Q3 2021) no longer reports it.

Position Value
$6M
Q2 2021
Shares
294.6K
% of Portfolio
+5.57%
Quarters Held
7
position exited

Position History CRNX

Reported value by quarter
Q4 ’19: $5MQ4 ’19Q1 ’20: $4MQ1 ’20Q2 ’20: $4MQ2 ’20Q3 ’20: $4MQ3 ’20Q4 ’20: $3MQ4 ’20Q1 ’21: $4MQ1 ’21Q2 ’21: $6MQ2 ’21filingsflow.com
QuarterSharesValue% of Portfolio
Q2 2021294.6K$6M+5.57%
Q1 2021272.4K$4M+3.37%
Q4 2020224.1K$3M+2.41%
Q3 2020241.3K$4M+2.98%
Q2 2020236.4K$4M+2.90%
Q1 2020282.3K$4M+3.96%
Q4 2019205.7K$5M+3.46%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Burrage Capital Management LLC’s full portfolio or all institutional holders of CRNX.